John Pløen

1.7k citations

34 papers · 1.2k indexed · 1 hit paper · h-index 15

Impact in

Oncology top 2%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
Radiation top 5%
- Advanced Radiotherapy Techniques

Papers in ⓘ

Oncology 28
- Colorectal Cancer Surgical Treatments 15
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 4
Biotechnology 6

Co-authors: Anders Jakobsen (27 shared papers)Jan Lindebjerg (18 shared papers)Ane Appelt (8 shared papers)Søren Rafael Rafaelsen (15 shared papers)Lars Henrik Jensen (12 shared papers)Jens Christian Riis Jørgensen (3 shared papers)Søren M. Bentzen (2 shared papers)Ivan R. Vogelius (2 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (4 papers)Annals of Oncology (4 papers)Acta Oncologica (4 papers)Colorectal Disease (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: Denmark United States Sweden

In The Last Decade

John Pløen

33 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study 2015 · 367 citations

Peers

Countries citing papers authored by John Pløen

Since Specialization

Citations

This map shows the geographic impact of John Pløen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pløen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pløen more than expected).

Fields of papers citing papers by John Pløen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Pløen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pløen. The network helps show where John Pløen may publish in the future.

Co-authors

The 25 scholars most cited alongside John Pløen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Pløen Line = papers co-authored together John Pløen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study The Lancet Oncology ·Ane Appelt, John Pløen, Henrik Harling, Frank Svendsen Jensen, Lars Henrik Jensen, Jens Christian Riis Jørgensen, Jan Lindebjerg, Søren Rafael Rafaelsen, Anders Jakobsen Hit paper breakdown →	2015	367
2	Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy International Journal of Radiation OncologyBiologyPhysics ·Ane Appelt, John Pløen, Ivan R. Vogelius, Søren M. Bentzen, Anders Jakobsen	2012	188
3	Neoadjuvant chemotherapy in locally advanced colon cancer.A phase II trial Acta Oncologica ·Anders Jakobsen, Fahimeh Andersen, Anders Fischer, Lars Henrik Jensen, Jens Christian Riis Jørgensen, Ole Larsen, Jan Lindebjerg, John Pløen, Søren Rafael Rafaelsen, Jesper Vilandt	2015	88
4	Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Annals of Oncology ·Lars Henrik Jensen, Jan Lindebjerg, John Pløen, Torben Frøstrup Hansen, Anders Jakobsen	2012	75
5	Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer: A Randomized Trial Comparing Two Radiation Doses International Journal of Radiation OncologyBiologyPhysics ·Anders Jakobsen, John Pløen, T. Vuong, Ane Appelt, Jan Lindebjerg, Søren Rafael Rafaelsen	2012	75
6	Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma Acta Oncologica ·Karen‐Lise Garm Spindler, Morten Mau‐Sørensen, Niels Pallisgaard, Rikke Fredslund Andersen, Birgitte Mayland Havelund, John Pløen, Ulrik Lassen, Anders Jakobsen	2013	46
7	Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan Scandinavian Journal of Gastroenterology ·A. Nørgaard, Claus Dam, Anders Jakobsen, John Pløen, Jan Lindebjerg, Søren Rafael Rafaelsen	2013	43
8	The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long‐course preoperative chemoradiotherapy Colorectal Disease ·Jan Lindebjerg, K.-L.G. Spindler, John Pløen, Anders Jakobsen	2008	39
9	Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost International Journal of Radiation OncologyBiologyPhysics ·Ane Appelt, Ivan R. Vogelius, John Pløen, Søren Rafael Rafaelsen, Jan Lindebjerg, Birgitte Mayland Havelund, Søren M. Bentzen, Anders Jakobsen	2014	37
10	Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer Nuclear Medicine Communications ·Birgitte Mayland Havelund, Paw Christian Holdgaard, Søren Rafael Rafaelsen, Lise Saksø Mortensen, Jörn Nielsen, Dirk Bender, John Pløen, Karen‐Lise Garm Spindler, Anders Jakobsen	2012	31
11	Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer International Journal of Radiation OncologyBiologyPhysics ·Edina Dizdarevic, Torben Frøstrup Hansen, John Pløen, Lars Henrik Jensen, Jan Lindebjerg, Søren Rafael Rafaelsen, Anders Jakobsen, Ane Appelt	2019	29
12	Ultrasound elastography in patients with rectal cancer treated with chemoradiation European Journal of Radiology ·Søren Rafael Rafaelsen, Chris Vagn-Hansen, Torben Sørensen, Jan Lindebjerg, John Pløen, Anders Jakobsen	2013	26
13	EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer Annals of Oncology ·K.-L.G. Spindler, Rikke Fredslund Andersen, Lars Henrik Jensen, John Pløen, Anders Jakobsen	2009	24
14	Study protocol designed to investigate tumour response to calcium electroporation in cancers affecting the skin: a non-randomised phase II clinical trial BMJ Open ·Mille Vissing, John Pløen, Mascha Pervan, Kitt Vestergaard, Mazen Schnefeldt, Stine K. Frandsen, Søren Rafael Rafaelsen, Christina Louise Lindhardt, Lars Henrik Jensen, Achim Rody, Julie Gehl	2021	14
15	Factors influencing reproducibility of tumour regression grading after high-dose chemoradiation of locally advanced rectal cancer Histopathology ·Jan Lindebjerg, Niels Hansborg, John Pløen, Søren Rafael Rafaelsen, Jens Christian Riis Jørgensen, Anders Jakobsen	2011	14
16	Gemcitabine and capecitabine for heavily pre-treated metastatic colorectal cancer patients--a phase II and translational research study. PubMed ·K.-L.G. Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, John Pløen, Anders Jakobsen	2014	14
17	Computed tomography assessment of early response to neoadjuvant therapy in colon cancer. PubMed ·Claus Dam, Vera Lund-Rasmussen, John Pløen, Anders Jakobsen, Søren Rafael Rafaelsen	2015	12
18	Immunohistological expression of HIF‐1α, GLUT‐1, Bcl‐2 and Ki‐67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer Apmis ·Birgitte Mayland Havelund, Flemming Brandt Sørensen, John Pløen, Jan Lindebjerg, Karen‐Lise Garm Spindler, Anders Jakobsen	2012	12
19	Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations International Journal of Cancer ·Nadia Emad Lotfi Amin, Torben Frøstrup Hansen, Eva Fernebro, John Pløen, Jakob Eberhard, Jan Lindebjerg, Lars Henrik Jensen	2021	10
20	Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil Annals of Oncology ·Camilla Qvortrup, M.K. Yilmaz, Dagfinn Øgreid, Åke Berglund, Lise Balteskard, John Pløen, Tone Fokstuen, Hans Starkhammar, Halfdan Sørbye, K S Tveit, Per Pfeiffer	2008	9

About John Pløen

John Pløen is a scholar working on Oncology, Biotechnology, Hepatology, Surgery and Radiation, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (15 papers), Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Gastric Cancer Management and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (1.0k citations), Radiation (146 citations), Surgery (728 citations), Radiology, Nuclear Medicine and Imaging (230 citations) and Pulmonary and Respiratory Medicine (282 citations). John Pløen has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Anders Jakobsen, Jan Lindebjerg, Ane Appelt, Søren Rafael Rafaelsen, Lars Henrik Jensen, Jens Christian Riis Jørgensen, Søren M. Bentzen, Ivan R. Vogelius, Henrik Harling and Frank Svendsen Jensen. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Acta Oncologica, Colorectal Disease and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact